Vantictumab (Anti-FZD)

製品コード：A2489         Batch: A248901

印刷

Vantictumab (Anti-FZD) is a monoclonal antibody targeting the Wnt signaling pathway with potential antineoplastic activity. Vantictumab binds to certain receptors in the Wnt signaling pathway thereby preventing the activation of the Wnt signaling pathway. This results in an inhibition of cancer stem cell (CSC) activity and a subsequent inhibition of cancer cell proliferation. MW: 145.5 KD.

製品説明

CAS No. 1345009-45-1
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Isotype Human IgG2SA
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 5.82mg/ml
Endotoxin Level ＜1EU/mg

人間や獣医の診断であるか治療的な使用のためにでない。